scholarly article | Q13442814 |
P50 | author | Eva Forssell-Aronsson | Q37369426 |
Ove Nilsson | Q42787164 | ||
Johan Mölne | Q42835621 | ||
Lars Kölby | Q56281793 | ||
P2093 | author name string | Ahlman H | |
Wängberg B | |||
Tisell LE | |||
Bernhardt P | |||
Hashemi SH | |||
Bejegård SA | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 636-642 | |
P577 | publication date | 2000-04-01 | |
P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
P1476 | title | 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors | |
P478 | volume | 41 |
Q44661143 | 99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans. |
Q44561169 | DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals |
Q57279912 | Differentiated thyroid cancer theranostics: radioiodine and beyond |
Q39805119 | Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT. |
Q37107084 | Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation |
Q24657586 | Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis |
Q41060321 | Incidentally Detected Thyroid Follicular Neoplasm on Somatostatin Receptor Imaging and Post-therapy Scan |
Q44780806 | Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value |
Q44443652 | Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131 |
Q38601787 | Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid |
Q62863996 | Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism |
Q37402609 | Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis |
Q35750002 | Potential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in Mice |
Q43876300 | Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer |
Q31137298 | SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells |
Q79361094 | Somatostatin and thyroid |
Q45244510 | Somatostatin receptor expression in thyroid disease |
Q39194102 | Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro. |
Q35682070 | Utility of (99m)Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer Patients with Elevated Serum Thyroglobulin Levels |
Search more.